Market Access News | pharmaphorum

News

Data hackathon analyses truth behind ‘game-changer’ COVID vaccine

Novavax gets first authorisation for its COVID-19 jab

Novavax has been granted its first emergency use authorisation in Indonesia for COVID-19 vaccine NVX-CoV2373, and expects other regulators in India, the Philippines and other countries to f

News

FDA delays review of Moderna COVD jab in adolescents

The FDA has said it needs more time to review Moderna's application for emergency use of its COVID-19 vaccine mRNA-1273 in children aged 12 to 17, as it looks at data on heart inflammation

News

AbbVie claims first FDA okay for presbyopia drug therapy

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near ob

News

Merck takes further steps to expand access to oral COVID pil...

Merck & Co has signed a licensing deal with the UN-backed Medicines Patent Pool (MPP) that could pave the way for generic companies to manufacture its much-anticipated oral antiviral fo

News

Lilly files Alzheimer's drug donanemab as Cortexyme rival fa...

Eli Lilly has followed through on its plan to file for approval of its Alzheimer's disease candidate donanemab, and is planning to take on Biogen and Eisai with a head-to-head trial against

News

Seagen's breast cancer drug Tukysa turned down by NICE

NICE has decided not to recommend Seagen's orally-active HER2 inhibitor Tukysa for advanced breast cancer in draft guidance, saying it isn't a cost-effective use of NHS resources.<

Novavax gets first authorisation for its COVID-19 jab

FDA delays review of Moderna COVD jab in adolescents

AbbVie claims first FDA okay for presbyopia drug therapy

Merck takes further steps to expand access to oral COVID pil...

Lilly files Alzheimer's drug donanemab as Cortexyme rival fa...

Seagen's breast cancer drug Tukysa turned down by NICE

FDA starts review of Regeneron's drug for rare disease FOP

How to meet your physicians where they are online

News

Editor's Picks